NANOVIRICIDES, INC. Litigation Settlement, Expense
NANOVIRICIDES, INC. (NNVC) reported Litigation Settlement, Expense of $150.00 thousand for the 6-month period ending 2014-12-31, per its 10-Q filed 2015-02-25.
Discontinued › Expense Statement › Operating Expenses
us-gaap:LitigationSettlementExpense · last filed 2015-02-25
- NANOVIRICIDES, INC. litigation settlement, expense for the quarter ending 2014-12-31 was $0.00.
- NANOVIRICIDES, INC. litigation settlement, expense for the quarter ending 2014-09-30 was $150.00K.
| Period end | Litigation Settlement, Expense | Litigation Settlement, Expense 1 month | Litigation Settlement, Expense 3 month | Litigation Settlement, Expense 6 month |
|---|---|---|---|---|
| 2014-12-31 | $0.00 derived: 10-Q 6 month − 10-Q/A 3 month · filed 2015-02-25 | $150.00K 10-Q · filed 2015-02-25 | ||
| 2014-09-30 | $150.00K 10-Q/A · filed 2015-02-23 | |||
| 2011-12-31 | $40.00K 10-K/A · filed 2013-10-08 | |||
| 2011-11-30 | $40.00K 10-K/A · filed 2012-10-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |